The present invention is directed to compounds of Formula I: I (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors an
-
(2008/12/07)
More Articles about upstream products of 1059186-52-5